One Day Advisor

Investing › AI Tools › Updated October 16, 2026 · Originally published July 30, 2026 Reviewed by: Frank Yap, MBA | Written by: One Day Advisor Editorial Team Quick Answer There is no single best AI for investment research in 2026. AlphaSense and Hebbia serve institutions, and ChatGPT for Financial Services is limited to eligible financial institutions. Most individual investors do well with Perplexity Finance for cited, real-time answers, Claude or ChatGPT for reading filings and building models, and Koyfin or TIKR for data. Verify every figure against the primary filing before acting. What changed in the October 2026 update AlphaSense raised $350 million at a $7.5 billion valuation (June 2026), reported ARR above $600 million, and added the SuperAnalyst agent plus Excel and PowerPoint assistants. Perplexity added broker...

Home  ›  AI  ›  Top Fast-Growing AI Digital Health Companies (2026 Update) Originally published February 9, 2025  |  Updated September 13, 2026 by the Editorial Team Quick Answer The digital health landscape has split in two since our original 2025 list. On the public markets, Hinge Health (HNGE) , Tempus AI (TEM) , and Hims & Hers Health (HIMS) delivered the fastest 2026 revenue growth, while Doximity (DOCS) and Teladoc Health (TDOC) show how differently two "AI turnaround" stories can play out. Privately, OpenEvidence (~$12 billion valuation, reportedly in talks for up to $20 billion) and Abridge ($5.3 billion) have become the two biggest capital magnets in all of digital health by building AI tools physicians actually use daily. Of the five companies on our original 2025 list, two (Doximity, Teladoc) are still public and volatile, one (Sword Health) expanded into mental health at a steady $4 billion valuat...